On Monday, Zymeworks BC Inc (NASDAQ: ZYME) was -7.50% drop from the session before settling in for the closing price of $12.00. A 52-week range for ZYME has been $7.97 – $17.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 273.04% over the last five years. When this article was written, the company’s average yearly earnings per share was at 1.18%. With a float of $67.30 million, this company’s outstanding shares have now reached $68.96 million.
The firm has a total of 286 workers. Let’s measure their productivity. In terms of profitability, gross margin is 50.29%, operating margin of -157.03%, and the pretax margin is -152.82%.
Zymeworks BC Inc (ZYME) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zymeworks BC Inc stocks. The insider ownership of Zymeworks BC Inc is 4.07%, while institutional ownership is 95.28%. The most recent insider transaction that took place on Jan 16 ’25, was worth 1,689,541. In this transaction Director of this company bought 121,681 shares at a rate of $13.88, taking the stock ownership to the 15,700,413 shares. Before that another transaction happened on Jan 17 ’25, when Company’s Director bought 19,748 for $13.87, making the entire transaction worth $273,998. This insider now owns 15,720,161 shares in total.
Zymeworks BC Inc (ZYME) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.78% during the next five years compared to 15.81% growth over the previous five years of trading.
Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators
You can see what Zymeworks BC Inc (ZYME) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -0.80 in one year’s time.
Technical Analysis of Zymeworks BC Inc (ZYME)
Analysing the last 5-days average volume posted by the [Zymeworks BC Inc, ZYME], we can find that recorded value of 0.93 million was better than the volume posted last year of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 11.52%. Additionally, its Average True Range was 0.76.
During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 1.93%, which indicates a significant decrease from 3.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.63% in the past 14 days, which was higher than the 56.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.07, while its 200-day Moving Average is $12.29. Now, the first resistance to watch is $11.64. This is followed by the second major resistance level at $12.17. The third major resistance level sits at $12.51. If the price goes on to break the first support level at $10.77, it is likely to go to the next support level at $10.43. Now, if the price goes above the second support level, the third support stands at $9.90.
Zymeworks BC Inc (NASDAQ: ZYME) Key Stats
There are 69,577K outstanding shares of the company, which has a market capitalization of 778.63 million. As of now, sales total 76,010 K while income totals -118,670 K. Its latest quarter income was 16,000 K while its last quarter net income were -29,850 K.
